Autoimmune hepatitis is a chronic inflammatory liver disease in which the immune system attacks the body's own organ. The disease is rare: in Europe it is detected in 16–18 people per 100,000 population. Most patients have predominantly nonspecific symptoms.
What autoimmune hepatitis is
This is inflammation of the liver caused not by a virus or alcohol but by the body's own immune system. The disease is classified as immune-mediated: specific autoantibodies appear in the blood, and the level of gamma globulins rises. The course is chronic and relapsing, with a high risk of cirrhosis. Two types are distinguished: in the first, antinuclear antibodies and antibodies to smooth muscle are found; in the second, antibodies to liver and kidney microsomes.
Why autoimmune hepatitis develops
The exact cause is unknown. The most likely hypothesis is the influence of environmental factors on the immune system in genetically predisposed people. Women predominate among patients. The incidence has two peaks — at 20–30 years and at 50–70 years, although the disease can begin at any age. Such patients often also have other immune-mediated conditions: autoimmune thyroiditis, rheumatoid arthritis, Sjögren's disease, vitiligo, inflammatory bowel diseases.
Symptoms of autoimmune hepatitis
Some people have no symptoms at all, and the disease is discovered incidentally by tests. When signs are present, nonspecific ones predominate: weakness, increased fatigue, joint pain, nausea, poor appetite, heaviness or pain in the liver area, jaundice. In 25% of cases the onset is acute, up to fulminant hepatitis. Progression to cirrhosis is suggested by marked jaundice, an expanded venous network on the anterior abdominal wall, and bleeding from the upper gastrointestinal tract.
How autoimmune hepatitis is diagnosed
There is no single test. The diagnosis is made based on a combination of medical history, examination, blood tests, imaging, and liver biopsy. In laboratory testing, clinicians look for a predominance of ALT over AST, an increase in IgG by more than 1.5 times, and a positive titer of specific autoantibodies. Other causes must be excluded: viral hepatitis A, B, C, E, toxic injury, hemochromatosis, alpha-1 antitrypsin deficiency, Wilson's disease. The "gold standard" is liver biopsy with micromorphological examination.
Why the disease is dangerous and what complications occur
Without treatment, inflammation progresses. The key complications are cirrhosis, liver failure, and liver cancer; if failure or a tumor develops, a liver transplant may be needed. Cirrhosis in autoimmune hepatitis develops rapidly; in some patients chronic hepatitis and cirrhosis form almost simultaneously. In children the course is more aggressive: at the time of diagnosis, 43.7% of children with type 1 and 70% with type 2 already had established cirrhosis.
How long people live with autoimmune hepatitis
There is no universal life expectancy figure for autoimmune hepatitis; it is known that without treatment the disease can lead to cirrhosis. Historically, autoimmune hepatitis became the first liver disease in which drug treatment was proven to increase patients' life expectancy. The doctor assesses inflammation activity by the level of ALT, AST, and IgG.
The disease itself is not a reason to call an ambulance. Call 103 or 112 if bleeding from the upper gastrointestinal tract appears, there is a sharp deterioration in condition, or signs of acute liver failure occur.
- Weakness and increased fatigue
- Joint pain
- Nausea and poor appetite
- Pain or heaviness in the liver area
- Jaundice — yellowing of the skin and eyes
This material is for reference: it explains the essence of the diagnosis but does not replace consultation with a doctor, who personally evaluates the tests and the condition of the liver.
Sources
Update history
Reader reviews
No reviews yet — tell us whether this article was helpful.
Leave a review
This content is for reference and does not replace a doctor's consultation. Medical disclaimer